• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

circ_0001588 通过调节 miR-874/CDK4 信号通路诱导肝癌的恶性进展。

circ_0001588 Induces the Malignant Progression of Hepatocellular Carcinoma by Modulating miR-874/CDK4 Signaling.

机构信息

College of Basic Medical Sciences, Youjiang Medical University for Nationalities, Baise, China.

Department of Hepatobiliary Surgery, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.

出版信息

J Immunol Res. 2021 Oct 20;2021:3759879. doi: 10.1155/2021/3759879. eCollection 2021.

DOI:10.1155/2021/3759879
PMID:34722778
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8550835/
Abstract

Accumulating evidence indicates that circular RNAs (circRNAs) can interact with microRNAs to modulate gene expression in various cancers, including hepatocellular carcinoma (HCC). Although the significant role of circRNAs has been well documented in HCC, the complex mechanisms of circRNAs still need to be elucidated. Our current study is aimed at investigating the function of circ_0001588 in HCC, which was observed to significantly increase in HCC tissues and cells. We demonstrated that the knockdown of circ_0001588 resulted in repressed cell proliferation, migration, and invasion. studies using a nude mouse model showed that circ_0001588 downregulation reduced tumor size. Moreover, miR-874 was predicted as a target of circ_0001588. Using luciferase binding assays, we proved that circ_0001588 functions as a molecular ceRNA of miR-874 and that CDK4 acts as a downstream target of miR-874 in HCC. It was confirmed that overexpression of miR-874 decreased the proliferation, migration, and invasion triggered by the increase in circ_0001588. In summary, our results indicate that circ_0001588 acts as a ceRNA and promotes HCC progression by targeting the miR-874/CDK4 signaling pathway. Hence, we propose that circ_0001588 may be a promising target for HCC treatment.

摘要

越来越多的证据表明,环状 RNA(circRNAs)可以与 microRNAs 相互作用,调节包括肝细胞癌(HCC)在内的多种癌症中的基因表达。尽管 circRNAs 在 HCC 中的重要作用已得到充分证实,但 circRNAs 的复杂机制仍有待阐明。我们目前的研究旨在研究 circ_0001588 在 HCC 中的功能,该 circRNA 在 HCC 组织和细胞中显著增加。我们证明,circ_0001588 的敲低导致细胞增殖、迁移和侵袭受到抑制。使用裸鼠模型的研究表明,circ_0001588 的下调降低了肿瘤的大小。此外,miR-874 被预测为 circ_0001588 的靶标。通过荧光素酶结合测定,我们证明 circ_0001588 作为 miR-874 的分子 ceRNA 发挥作用,并且 CDK4 是 HCC 中 miR-874 的下游靶标。证实过表达 miR-874 可降低 circ_0001588 增加引发的增殖、迁移和侵袭。综上所述,我们的研究结果表明,circ_0001588 通过靶向 miR-874/CDK4 信号通路作为 ceRNA 促进 HCC 进展。因此,我们提出 circ_0001588 可能是 HCC 治疗的有前途的靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43c5/8550835/abf08c96f64c/JIR2021-3759879.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43c5/8550835/b994a0b3c3ff/JIR2021-3759879.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43c5/8550835/d1aca8d9a513/JIR2021-3759879.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43c5/8550835/57dfa8a85428/JIR2021-3759879.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43c5/8550835/590897da7442/JIR2021-3759879.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43c5/8550835/092850ce9a1d/JIR2021-3759879.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43c5/8550835/abf08c96f64c/JIR2021-3759879.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43c5/8550835/b994a0b3c3ff/JIR2021-3759879.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43c5/8550835/d1aca8d9a513/JIR2021-3759879.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43c5/8550835/57dfa8a85428/JIR2021-3759879.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43c5/8550835/590897da7442/JIR2021-3759879.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43c5/8550835/092850ce9a1d/JIR2021-3759879.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43c5/8550835/abf08c96f64c/JIR2021-3759879.006.jpg

相似文献

1
circ_0001588 Induces the Malignant Progression of Hepatocellular Carcinoma by Modulating miR-874/CDK4 Signaling.circ_0001588 通过调节 miR-874/CDK4 信号通路诱导肝癌的恶性进展。
J Immunol Res. 2021 Oct 20;2021:3759879. doi: 10.1155/2021/3759879. eCollection 2021.
2
Circ_0001178 regulates miR-382/VEGFA axis to facilitate hepatocellular carcinoma progression.环状 RNA 0001178 通过调控 miR-382/VEGFA 轴促进肝癌进展。
Cell Signal. 2020 Aug;72:109621. doi: 10.1016/j.cellsig.2020.109621. Epub 2020 Mar 30.
3
Circ_0015756 promotes proliferation, invasion and migration by microRNA-7-dependent inhibition of FAK in hepatocellular carcinoma.环状 RNA 0015756 通过 microRNA-7 依赖抑制 FAK 促进肝癌的增殖、侵袭和迁移。
Cell Cycle. 2019 Nov;18(21):2939-2953. doi: 10.1080/15384101.2019.1664223. Epub 2019 Sep 16.
4
Circular RNA circ-102,166 acts as a sponge of miR-182 and miR-184 to suppress hepatocellular carcinoma proliferation and invasion.环状RNA circ-102,166作为miR-182和miR-184的海绵,抑制肝细胞癌的增殖和侵袭。
Cell Oncol (Dordr). 2021 Apr;44(2):279-295. doi: 10.1007/s13402-020-00564-y. Epub 2020 Oct 9.
5
circRNA hsa_circ_104566 Sponged miR-338-3p to Promote Hepatocellular Carcinoma Progression.环状 RNA hsa_circ_104566 通过海绵吸附 miR-338-3p 促进肝癌进展。
Cell Transplant. 2020 Jan-Dec;29:963689720963948. doi: 10.1177/0963689720963948.
6
Silencing of hsa_circ_0101145 reverses the epithelial-mesenchymal transition in hepatocellular carcinoma via regulation of the miR-548c-3p/LAMC2 axis.hsa_circ_0101145 的沉默通过调节 miR-548c-3p/LAMC2 轴逆转肝癌中的上皮-间充质转化。
Aging (Albany NY). 2020 Jun 18;12(12):11623-11635. doi: 10.18632/aging.103324.
7
Circular RNA hsa_circ_0016788 regulates hepatocellular carcinoma tumorigenesis through miR-486/CDK4 pathway.环状 RNA hsa_circ_0016788 通过 miR-486/CDK4 通路调控肝细胞癌肿瘤发生。
J Cell Physiol. 2018 Jan;234(1):500-508. doi: 10.1002/jcp.26612. Epub 2018 Jun 19.
8
Exosomal hsa_circ_0004658 derived from RBPJ overexpressed-macrophages inhibits hepatocellular carcinoma progression via miR-499b-5p/JAM3.外泌体 hsa_circ_0004658 来源于过表达 RBPJ 的巨噬细胞,通过 miR-499b-5p/JAM3 抑制肝癌进展。
Cell Death Dis. 2022 Jan 10;13(1):32. doi: 10.1038/s41419-021-04345-9.
9
Hsa_circ_0026134 expression promoted TRIM25- and IGF2BP3-mediated hepatocellular carcinoma cell proliferation and invasion via sponging miR-127-5p.Hsa_circ_0026134 的表达通过海绵吸附 miR-127-5p 促进 TRIM25 和 IGF2BP3 介导的肝癌细胞增殖和侵袭。
Biosci Rep. 2020 Jul 31;40(7). doi: 10.1042/BSR20191418.
10
Circ-EIF3I Promotes Hepatocellular Carcinoma Progression Through Modulating miR-361-3p/DUSP2 Axis.环状 RNA EIF3I 通过调控 miR-361-3p/DUSP2 轴促进肝癌进展。
DNA Cell Biol. 2024 May;43(5):258-266. doi: 10.1089/dna.2023.0400. Epub 2024 Mar 22.

引用本文的文献

1
Hsa_circ_0016662 acts as a prognostic biomarker and promotes the progression of hepatocellular carcinoma via autophagy regulation.Hsa_circ_0016662作为一种预后生物标志物,通过自噬调节促进肝细胞癌的进展。
J Transl Med. 2025 Jul 1;23(1):714. doi: 10.1186/s12967-025-06763-1.
2
hsa_circ_0008305 facilitates the malignant progression of hepatocellular carcinoma by regulating AKR1C3 expression and sponging miR-379-5p.hsa_circ_0008305通过调控AKR1C3的表达及吸附miR-379-5p促进肝细胞癌的恶性进展。
Sci Rep. 2025 Jan 8;15(1):1309. doi: 10.1038/s41598-025-85737-1.
3
Whole-transcriptome sequencing with ceRNA regulation network construction and verification in glioblastoma.

本文引用的文献

1
Circular RNA hsa_circ_0001588 promotes the malignant progression of lung adenocarcinoma by modulating miR-524-3p/NACC1 signaling.环状 RNA hsa_circ_0001588 通过调控 miR-524-3p/NACC1 信号通路促进肺腺癌的恶性进展。
Life Sci. 2020 Oct 15;259:118157. doi: 10.1016/j.lfs.2020.118157. Epub 2020 Jul 28.
2
Circular RNA hsa_circ_0000326 acts as a miR-338-3p sponge to facilitate lung adenocarcinoma progression.环状 RNA hsa_circ_0000326 作为 miR-338-3p 的海绵体促进肺腺癌进展。
J Exp Clin Cancer Res. 2020 Apr 5;39(1):57. doi: 10.1186/s13046-020-01556-4.
3
Embolotherapeutic Strategies for Hepatocellular Carcinoma: 2020 Update.
胶质母细胞瘤中全转录组测序及ceRNA调控网络的构建与验证
Am J Transl Res. 2023 Jun 15;15(6):4291-4313. eCollection 2023.
4
Identification of immune-related genes and patient selection for hepatocellular carcinoma immunotherapy.肝细胞癌免疫治疗免疫相关基因的鉴定及患者选择
Transl Cancer Res. 2023 May 31;12(5):1210-1231. doi: 10.21037/tcr-22-2304. Epub 2023 Apr 13.
5
Screening and analysis of differentially expressed circRNAs and miRNAs in chronic diabetic extremity wounds.慢性糖尿病肢体伤口中差异表达的环状RNA和微小RNA的筛选与分析
Front Surg. 2022 Nov 10;9:1007312. doi: 10.3389/fsurg.2022.1007312. eCollection 2022.
6
Competing endogenous RNA networks related to prognosis in chronic lymphocytic leukemia: comprehensive analyses and construction of a novel risk score model.与慢性淋巴细胞白血病预后相关的竞争性内源性RNA网络:综合分析及新型风险评分模型的构建
Biomark Res. 2022 Oct 21;10(1):75. doi: 10.1186/s40364-022-00423-y.
7
A review on the role of cyclin dependent kinases in cancers.细胞周期蛋白依赖性激酶在癌症中的作用综述。
Cancer Cell Int. 2022 Oct 20;22(1):325. doi: 10.1186/s12935-022-02747-z.
肝细胞癌的栓塞治疗策略:2020年更新
Cancers (Basel). 2020 Mar 26;12(4):791. doi: 10.3390/cancers12040791.
4
The biogenesis and biological functions of circular RNAs and their molecular diagnostic values in cancers.环状 RNA 的生物发生和生物学功能及其在癌症中的分子诊断价值。
J Clin Lab Anal. 2020 Jan;34(1):e23049. doi: 10.1002/jcla.23049. Epub 2019 Sep 25.
5
CircRNA UBAP2 promotes the progression of ovarian cancer by sponging microRNA-144.环状 RNA UBAP2 通过海绵吸附 microRNA-144 促进卵巢癌的进展。
Eur Rev Med Pharmacol Sci. 2019 Sep;23(17):7283-7294. doi: 10.26355/eurrev_201909_18833.
6
CircRNAs in cancer metabolism: a review.环状 RNA 在癌症代谢中的作用:综述。
J Hematol Oncol. 2019 Sep 4;12(1):90. doi: 10.1186/s13045-019-0776-8.
7
The biogenesis, biology and characterization of circular RNAs.环状 RNA 的生物发生、生物学和特征。
Nat Rev Genet. 2019 Nov;20(11):675-691. doi: 10.1038/s41576-019-0158-7. Epub 2019 Aug 8.
8
Circular RNA circRHOT1 promotes hepatocellular carcinoma progression by initiation of NR2F6 expression.环状 RNA circRHOT1 通过启动 NR2F6 表达促进肝细胞癌进展。
Mol Cancer. 2019 Jul 19;18(1):119. doi: 10.1186/s12943-019-1046-7.
9
Circular RNAs in hepatocellular carcinoma: Biomarkers, functions and mechanisms.环状 RNA 在肝细胞癌中的作用:生物标志物、功能和机制。
Life Sci. 2019 Aug 15;231:116660. doi: 10.1016/j.lfs.2019.116660. Epub 2019 Jul 15.
10
Circular RNA circTRIM33-12 acts as the sponge of MicroRNA-191 to suppress hepatocellular carcinoma progression.环状 RNA circTRIM33-12 作为 MicroRNA-191 的海绵体抑制肝癌进展。
Mol Cancer. 2019 Jun 1;18(1):105. doi: 10.1186/s12943-019-1031-1.